Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...
SRM Global Hospitals successfully treated an 80-year-old patient with irregular heart rhythm using advanced TactiFlex catheter ablation technology.
MIT-alumni-founded Thermedical advances novel deep-tissue ablation technology to address critical unmet needs in severe ventricular tachycardia ...
Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...
LA Chargers coach Jim Harbaugh is having a cardiac ablation during the offseason. It's a procedure to treat an irregular heart rhythm. The procedure involves creating tiny scars in the heart that then ...
Zacks Investment Research on MSN
PLSE wins FDA IDE approval to launch nPulse AF ablation study trial
Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to ...
NFL players, coaches and staff put their bodies on the line every season. They sacrifice health, time, energy and more for a chance to win a Super Bowl. When that season eventually comes to an end, it ...
Dealing with both type 2 diabetes and atrial fibrillation made it twice as difficult for Matt Jewell to live a healthy lifestyle. Medicine to control his abnormal heart rhythm slowed down his heart ...
A doctor may recommend surgery for arrhythmia when medications and lifestyle changes haven’t been effective. The different types of arrhythmia surgeries each aim to restore a regular heart rhythm.
Jim Harbaugh told reporters Tuesday he had two successful surgeries during the 2025 NFL offseason. One was a hip replacement; the other was a cardiac ablation done after the 61-year-old coach ...
Cardiac Ablation Market by Trends, Dynamic Innovation in Technology Key Players and Forecast to 2030
Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results